Advisory Committee on Immunization Practices.General recommendations on immunization. MMWR.1994; 43(RR-1): 1–38.
2.
Centers for Disease Control and Prevention.Standards for pediatric immunization. MMWR.1993; 42(RR-5): 1–13.
3.
PeterG., ed. 2000 Red Book: Report of the Committee on Infectious Diseases.25th ed.Elk Grove Village, IL: American Academy of Pediatrics; 2000.
4.
National Coalition for Adult Immunization.Standards for adult immunization. Am J Hosp Pharm.1990; 47: 2348.
5.
American College of Physicians.Guide for Adult Immunization.3rd ed.Philadelphia: American College of Physicians; 1994.
6.
American Pharmaceutical Association.Guidelines for Pharmacy-Based Immunization Delivery.Washington, DC: American Pharmaceutical Association; August 1997.
American Society of Consultant Pharmacists.Guidelines on the role of the consultant pharmacist in immunization programs for long-term care environments.Alexandria, VA: American Society of Consultant Pharmacists; August 1998.
9.
National Vaccine Advisory Committee.Adult immunization programs in nontraditional settings: Quality standards and guidance for program evaluation. MMWR.2000; 49(RR-1): 1–13.
10.
GrabensteinJ.D.ImmunoFacts: Vaccines and Immunologic Drugs. 19th revision. St. Louis: Facts & Comparisons, Inc.; August 2000.
11.
AtkinsonW., WolfeC., HumistonS., NelsonR., ed. Epidemiology and Prevention of Vaccine-Preventable Diseases.6th ed.Atlanta, GA: Centers for Disease Control and Prevention; 2000.
12.
GrabensteinJ.D.Pharmacists as vaccine advocates: Roles in community pharmacies, nursing homes, and hospitals. Vaccine.1998; 16: 705–10.
13.
American Society of Hospital Pharmacists.Technical Assistance Bulletin (TAB) on the Pharmacist's Role in Immunization. Am J Hosp Pharm.1993; 50: 501–5.
14.
Advisory Committee on Immunization Practices.Use of standing orders programs to increase adult vaccination rates. MMWR.2000; 49(RR-1): 15–26.
15.
GrabensteinJ.D.The importance of up-to-date Vaccine Information Statements. Hosp Pharm.1999; 34: 1072–3, 1076–8, 1081–2,1085–7.
GrabensteinJ.D.Clinical management of hypersensitivities to vaccine components. Hosp Pharm.1997; 32: 77–8, 81–4,87.
18.
GrabensteinJ.D.Vaccines and antibodies in relation to pregnancy and lactation. Hosp Pharm.1999; 34: 949–52, 955–6,959–60.
19.
GrabensteinJ.D.Vaccine misconceptions and inappropriate contraindications lead to preventable illness and death. Hosp Pharm.1998; 33: 1557–8, 1561–4,1567.
20.
Advisory Committee on Immunization Practices.Prevention of pneumococcal disease. MMWR.1997; 46(RR-8): 1–24.
21.
JacksonL.A., BensonP., SnellerV.P.Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA.1999; 281: 243–8.
